Don’t miss important information that may help you achieve the anesthesia outcomes you want

Be one of the first to receive Remi* resources right in your inbox, including app updates and new anesthesia plans. Sign up today.

For US healthcare professionals only.

Please enter your email address.
Please enter a valid email address.
Please enter your zip code.

Mylan understands that your patients’ health information as well as your personal and professional information is private. All information you provide will only be used by Mylan and trusted parties acting on its behalf to send you materials you requested and other helpful information and special offers about ULTIVA® (remifentanil HCl) for Injection, as well as related treatments, products, offers and services. You may opt out of receiving these communications at any time. Should you decide to receive additional information from Mylan and the ULTIVA Team, please note that this website is intended for residents of the United States. As such, by opting-in to receive our communications you confirm that you are a resident of the United States and eligible to receive such communications. To learn about how Mylan uses your information, please view our Privacy Statement.

*Remifentanil is commonly referred to as Remi by anesthesia providers.